Publication | Closed Access

Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability

Phthalimide-triazole AgentsCombinatorial ChemistryMedicinal ChemistryMetabolic StabilityBiochemistryMedicineNatural SciencesMolecular HybridsAnti-cancer AgentDrug DevelopmentPharmacologyDrug Discovery